Lecicarbon Pediatrickí Pacienti (Sodium Hydrogen Carbonate, Sodium Dihydrogen Phosphate)

Both compounds dissociate to release bicarbonate and phosphate ions. These ions bind hydrogen ions in the rectal lumen, forming water and carbonic acid, which raises the local pH. The resulting buffering effect reduces acidity and supports systemic acid‑base homeostasis in children.

The appropriate dose is determined by the prescribing clinician based on the child’s age, weight, clinical condition, and laboratory values. Healthcare providers calculate the exact amount needed to achieve the desired buffering effect and adjust it according to response and safety monitoring.

Safety data for use in pregnancy or lactation are limited. The product should only be used if the potential benefit to the mother or child outweighs any possible risk. Consultation with a specialist obstetrician or pediatrician is recommended before prescribing.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Unlike oral sodium bicarbonate solutions, Lecicarbon Pediatrickí is formulated for rectal delivery, which can be advantageous when oral intake is limited or rapid local buffering is needed. It combines both bicarbonate and phosphate, offering a broader buffering capacity compared with single‑component agents.

Store the product below 25 °C in its original container, protecting it from moisture, heat and direct sunlight. Ensure the packaging remains sealed until use, and keep it out of reach of children. No refrigeration is required for this rectal formulation.

The medication is given rectally, typically as a suppository or enema. The caregiver inserts the prescribed amount into the rectum according to the instructions provided by the healthcare professional, ensuring proper positioning and hygiene to maximize absorption and comfort.

Serious adverse events include severe electrolyte disturbances such as hypernatremia or hypophosphatemia, severe abdominal pain or colitis, and allergic reactions that may progress to anaphylaxis. Prompt medical attention is required if any of these symptoms develop.

The product should be avoided in children with known hypersensitivity to sodium bicarbonate or phosphate salts, those with severe hypernatremia, marked phosphate imbalance, or certain renal conditions where electrolyte handling is compromised. Contraindications must be confirmed by the prescribing clinician.